Navigation Links
Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
Date:2/5/2008

CHICAGO, Feb. 5 /PRNewswire-USNewswire/ -- In response to the growing need for competent industry professionals, Northwestern University has created a graduate certificate program in Clinical Research and Regulatory Administration http://www.scs.northwestern.edu/grad/crra/.

Northwestern University School of Continuing Studies (SCS), in partnership with Northwestern University Clinical and Translational Sciences Institute (NUCATS), will launch the new program this spring with a Feb. 22, 2008, application deadline and a March 31, 2008, program start date. Applications accepted for fall start as well.

The four-course, graduate certificate curriculum grounds professionals in the key concepts of the clinical research enterprise and allows them to focus in one of two research areas: regulatory affairs and administration, or clinical trials design and conduct. The program enables research professionals to develop competency at the site and clinical operations levels.

Program Outcomes

At the conclusion of the graduate certificate, students will have demonstrated expertise in:

-- Understanding the current regulatory environment in clinical research,

-- Interpreting regulatory requirements and applying them to various roles in the clinical research and drug/device development process,

-- Creating systems and processes to assure quality research outcomes, and

-- Fostering a climate of excellence in clinical research and research and regulatory administration.

Industry Outlook

Career advancement opportunities abound for the effective clinical research professional at academic medical centers, research sites, and in pharmaceutical and medical device organizations.

Recent growth in clinical and translational research has heightened the need for a competent clinical research work force in industry and academia. While government organizations re-engineer the clinical research enterprise and ensure compliance with federal regulations, pharmaceutical companies seek to improve the breadth and efficiency of clinical research and maintain quality and safety standards. As a result, pharmaceutical companies and research sites must ensure that the research process is safe, efficient, and compliant. There is also focus on bringing much-needed products to market in a reasonable time frame to improve patient health. These requirements demand a highly skilled clinical research team with a knowledge and skill base surrounding clinical trial management, implementation, compliance, and regulatory affairs.

Northwestern University School of Continuing Studies offers working professionals the opportunity to continue their education through flexible evening programs. Visit http://www.scs.northwestern.edu for more information regarding programs and schedules for graduate and undergraduate degree and professional development certificate programs.


'/>"/>
SOURCE Northwestern University
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Northwestern Memorial Transplant Program Initiates New Study
2. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
3. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
4. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
5. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
6. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
7. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
8. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
9. Concentra Offers Flu Vaccines to Keep America Working
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. CVS/pharmacy Offers Flu Vaccinations in Over 4,000 Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... ... 2016 , ... Today, MTI-GlobalStem, a provider of optimized transfection ... to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System ... is a complete system for culturing and transfecting human pluripotent stem cells for ...
Breaking Medicine News(10 mins):